1) If I ran this place you'd be banned for the comment
1) If I ran this place you'd be banned for the comment about shooting someone. No questions. Done. How can someone be such a complete eff-tard day in, day out, I don't know.
2) The links I posted were suggested reading on twitter by J Napodano and he prefaced it with "FWIW". In my opinion, the writer rambles a bit too much and even reads like a conspiracy theorist at times. Perhaps the clinical work done on permaderm was sloppy but as GC said about Lympro, Provista developed that poorly, we're developing it well. He probably sees a similar opportunity with Permaderm.
You should go.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Rosanne Cash Exhibition at the Country Music Hall of Fame The Country Music Hall of Fame and Museum is set to showcase a remarkable exhibition centered on the influential career of Rosanne Cash. This exhibition, titled "Rosanne Cash: Time Is a Mirror," will delve into her extensive journey as an artist, encompassing her evolution as a songwriter and storyteller....
Continue Reading
Transforming Moving Services for Boston Residents Boston's vibrant atmosphere has led to an increased demand for efficient and modern moving solutions. Safe Responsible Movers is dedicated to meeting these needs, offering top-notch services tailored to the specific challenges that both residents and businesses experience. With a solid reputation established over the...
Continue Reading
Endeavour Mining's Recent Share Buyback Announcement Endeavour Mining plc has made a notable step in its commitment to returning value to shareholders through the recent purchase of its ordinary shares. The company has acquired shares from Stifel Nicolaus Europe Limited, marking a significant move in its ongoing buyback program. Aggregated Information on the Share...
Continue Reading
Kristi Vassak Takes on Key Role at Lenox Advisors Lenox Advisors, an esteemed wealth management and insurance advisory firm, has appointed Kristi Vassak as Chief Operating Officer. This significant promotion reflects not only her extensive tenure but also her transformative leadership within the company. As a long-term employee who joined the firm in 2005, Vassak has...
Continue Reading
Werewolf Therapeutics Engages at Kidney Cancer Research Summit WATERTOWN, Mass. — Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), a forward-thinking biopharmaceutical company, is making strides in its mission to revolutionize cancer treatment through conditionally activated therapeutics. This approach aims to empower the body’s immune system...
Continue Reading
